Incyte Corp (NASDAQ:INCY) Stock Sentiment Increases to 1.06

May 3, 2018 - By Joshua Cleveland

Incyte Corporation (NASDAQ:INCY) Corporate Logo

Incyte Corp’s Sentiment

“Big money sentiment for Incyte Corp (NASDAQ:INCY) in Q4 2017 increased to 1.06, SEC filings reveal. That’s up 0.02, from 2017Q3’s 1.04. 212 institutional investors opened new or increased stock positions, while 200 sold and decreased stock positions in Incyte Corp so the sentiment improved. These funds own 191.73 million shares, that’s up from 188.97 million shares in 2017Q3. Funds holding Incyte Corp in top 10 changed to 9 from 8 for an increase of 1. 59 Investors Sold All; 141 Reduced Holdings; 153 increased holdings while 59 institutional investors bought holdings.

Largest Incyte Corp Shareholders

As of Q4 2017 Baker Bros. Advisors Lp has 28.1% invested in Incyte Corp. Incyte Corp’s shareholder Bb Biotech Ag owns 3.70 million shares as of Q4 2017. Furthermore, Healthcor Management L.P. reported 1.35 million shares in Incyte Corp equivalent to 4.16% of its US equity exposure. The New York-based fund Ratan Capital Management Lp have invested about 4.07% of the institutional investor’s stock portfolio in Incyte Corp. The New York-based fund Bridger Management Llc looks positive on Incyte Corp, owning 622,152 shares.

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally.The company has $12.97 billion market cap. It offers JAKAFI for the treatment of myelofibrosis and polycythemia vera cancers.Last it reported negative earnings. The companyÂ’s clinical stage products include ruxolitinib cream that is in Phase II clinical trial for the treatment of alopecia areata and atopic dermatitis; and baricitinib, which is in Phase III clinical trial for treatment of rheumatoid arthritis.

Ticker’s shares touched $61.2142 during the last trading session after 0.27% change.Currently Incyte Corporation is downtrending after 39.22% change in last May 3, 2017. INCY has 44,641 shares volume. The stock underperformed the S&P 500 by 50.77%.

Fincl Architects holds 0.01% of its capital in Incyte Corporation (NASDAQ:INCY) for 365 shs. Lincoln National Corporation, Pennsylvania-based fund reported 5,180 shs. Goldman Sachs Group Inc Inc has 2.58 million shs. Franklin Street Advsr Nc holds 0.06% in Incyte Corporation (NASDAQ:INCY) or 4,000 shs. Amalgamated National Bank & Trust reported 22,951 shs stake. Opus Point Mgmt Limited holds 18,318 shs or 1.5% of its capital. Burt Wealth Advisors stated it has 2,188 shs. Parametric Portfolio Associate Ltd Limited Liability Company holds 0.02% or 233,760 shs in its capital. The New York-based Sg Americas Ltd Llc has invested 0.07% in Incyte Corporation (NASDAQ:INCY). Cornerstone Advsrs stated it has 900 shs. Federated Incorporated Pa invested in 0.08% or 292,329 shs. Rhenman & Prtnrs Asset Mgmt owns 163,703 shs. Moreover, Prudential Fincl has 0.03% invested in Incyte Corporation (NASDAQ:INCY) for 241,935 shs. State Of Tennessee Treasury Department holds 0.02% or 45,314 shs in its capital. Magnetar Finance Ltd Llc invested in 5,350 shs.

Incyte Corporation registered $1.00 million net activity with 0 insider buys and 3 sales since January 5, 2018. Another trade for 1,958 shs valued at $167,507 was made by Huber Reid M on Tuesday, February 20.

Incyte Corporation (NASDAQ:INCY) Ratings Coverage

In total 14 analysts cover Incyte Corp (NASDAQ:INCY). “Buy” rating has 9, “Sell” are 0, while 5 are “Hold”. 64% are bullish. 20 are the (NASDAQ:INCY)’s analyst reports since November 21, 2017 according to StockzIntelligence Inc. On Wednesday, April 4 the rating was maintained by RBC Capital Markets with “Buy”. On Tuesday, January 2 the firm earned “Buy” rating by BMO Capital Markets. The stock rating was maintained by Raymond James with “Buy” on Thursday, February 15. On Thursday, April 5 the rating was maintained by Barclays Capital with “Overweight”. On Tuesday, April 24 the stock of Incyte Corporation (NASDAQ:INCY) has “Overweight” rating given by JP Morgan. On Tuesday, May 1 the stock of Incyte Corporation (NASDAQ:INCY) has “Hold” rating given by Oppenheimer. On Monday, April 9 the stock of Incyte Corporation (NASDAQ:INCY) has “Outperform” rating given by Credit Suisse. On Thursday, February 15 the firm earned “Buy” rating by RBC Capital Markets. On Tuesday, November 21 the firm has “Hold” rating by RBC Capital Markets given. On Friday, April 6 the firm has “Buy” rating by SunTrust given.

Incyte Corporation (NASDAQ:INCY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.